All Stories

  1. Multiple facets of arrhythmogenic cardiomyopathy: the Fuwai classification of a unique disease based on clinical features, histopathology, and genotype
  2. Extended Use of the Wearable Cardioverter-Defibrillator: Which Patients Are Most Likely to Benefit?
  3. Response: Mechanism of intermittent PQ prolongation
  4. Multiple clinical profiles of families with the short QT syndrome
  5. Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome
  6. Corrigendum to “Falls and Fractures in the Elderly with Sinus Node Disease: The Impact of Pacemaker Implantation”
  7. Zurich International Symposium on Arrhythmogenic Right Ventricular Cardiomyopathies
  8. Arrhythmogene rechtsventrikuläre Kardiomyopathie / Dysplasie: Pathogenese, Diagnose und Therapie
  9. Myocardial expression profiles of candidate molecules in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia compared to those with dilated cardiomyopathy and healthy controls
  10. Intermittent PQ prolongation between two premature ventricular complexes: what is the mechanism?
  11. Atrial premature beats during the Mueller manoeuvre are a predictor for arrhythmias
  12. Arrhythmogenic Left Ventricular Cardiomyopathy
  13. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement
  14. Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
  15. Incidence and Prognosis of Ventricular Arrhythmias in Patients with Congenital Left Ventricular Aneurysms or Diverticula
  16. Intrathoracic pressure swings induced by simulated obstructive sleep apnoea promote arrhythmias in paroxysmal atrial fibrillation
  17. Atrial Arrhythmias in Arrhythmogenic Cardiomyopathy: At the Beginning or at the End of the Disease Story?
  18. Electrocardiographic features of disease progression in arrhythmogenic right ventricular cardiomyopathy/dysplasia
  19. Usefulness of Electrocardiographic Parameters for Risk Prediction in Arrhythmogenic Right Ventricular Dysplasia
  20. Robotic ablation of atrial fibrillation with a new remote catheter system
  21. Clinical Role of Atrial Arrhythmias in Patients With Arrhythmogenic Right Ventricular Dysplasia
  22. A Novel Electrocardiographic Index for the Diagnosis of Diastolic Dysfunction
  23. An Unusual Appearance of a Pacemaker Lead
  24. Holiday Heart Block: Alcohol-induced PR Prolongation
  25. Catheter ablation for atrial fibrillation in the elderly
  26. Exercise Testing for Risk Stratification of Ventricular Arrhythmias in the Athlete
  27. Atrial Fibrillation
  28. Usefulness of Inducible Ventricular Tachycardia to Predict Long-Term Adverse Outcomes in Arrhythmogenic Right Ventricular Cardiomyopathy
  29. Dronedarone reduces arterial thrombus formation
  30. Predictors of Appropriate ICD Therapy in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy: Long Term Experience of a Tertiary Care Center
  31. Duty-cycled unipolar/bipolar versus conventional radiofrequency ablation in paroxysmal and persistent atrial fibrillation
  32. Comparison of Benefit and Mortality of Implantable Cardioverter–Defibrillator Therapy in Patients Aged ≥75 Years Versus Those <75 Years
  33. Value of Electrocardiogram in the Differentiation of Hypertensive Heart Disease, Hypertrophic Cardiomyopathy, Aortic Stenosis, Amyloidosis, and Fabry Disease
  34. Falls and Fractures in the Elderly with Sinus Node Disease: The Impact of Pacemaker Implantation
  35. Arrhythmic Manifestations in Patients With Congenital Left Ventricular Aneurysms and Diverticula
  36. Elevated γ-glutamyltransferase in implantable cardioverter defibrillator patients
  37. Electrical Activation in the Coronary Sinus Branches as a Guide to Cardiac Resynchronisation Therapy: Rationale for a Coordinate System
  38. Appropriate Therapy But Not Inappropriate Shocks Predict Survival in Implantable Cardioverter Defibrillator Patients
  39. Rhythm disorders in isolated left ventricular noncompaction
  40. Atrial fibrillation in the aging heart: pharmacological therapy and catheter ablation in the elderly
  41. Management of Patients with Atrial Fibrillation: Specific Considerations for the Old Age
  42. Long-Term Follow-up of Patients With Isolated Left Ventricular Noncompaction
  43. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment
  44. Implantable cardioverter-defibrillator and cardiac resynchronization therapy in patients with left ventricular noncompaction
  45. Altered Left Ventricular Contraction Pattern during Right Ventricular Pacing: Assessment Using Real-Time Three-Dimensional Echocardiography
  46. Beta1-Adrenoceptor Polymorphism Predicts Flecainide Action in Patients with Atrial Fibrillation
  47. Ablation of atrial fibrillation after the retirement age: considerations on safety and outcome
  48. Heart Obeys the Brain: Seizure Ceases Cardiac Rhythm
  49. PQ Interval in Patients With Fabry Disease
  50. Double Transseptal Puncture for Catheter Ablation of Atrial Fibrillation: Safety of the Technique and Its Use in the Outpatient Setting
  51. Electrocardiographic Characteristics at Initial Diagnosis in Patients With Isolated Left Ventricular Noncompaction
  52. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a not so rare “disease of the desmosome” with multiple clinical presentations
  53. Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy During Long-Term Follow-up of Patients With Coronary Artery Disease
  54. Serological Evidence for the Association ofBartonella henselaeInfection with Arrhythmogenic Right Ventricular Cardiomyopathy
  55. Leisure-Time Activities of Patients with ICDs: Findings of a Survey with Respect to Sports Activity, High Altitude Stays, and Driving Patterns
  56. Implantable Cardioverter-Defibrillators in Patients with Left Ventricular Noncompaction
  57. Effects of AV delay programming on ventricular resynchronisation: role of radionuclide ventriculography
  58. Potential interference of small neodymium magnets with cardiac pacemakers and implantable cardioverter-defibrillators
  59. Improving SVT Discrimination in Single-Chamber ICDs: A New Electrogram Morphology-Based Algorithm
  60. Wavelet-Based Tachycardia Discrimination in ICDs: Impact of Posture and Electrogram Configuration
  61. Integration of B-Type Natriuretic Peptide Levels With Clinical Data and Exercise Testing for Predicting Coronary Artery Disease
  62. 3-D CT for cardiovascular treatment planning
  63. Commentary
  64. Induction Ovens and Electromagnetic Interference: 
What Is the Risk for Patients with Implantable Cardioverter Defibrillators?
  65. Automatic Impedance Monitoring and Patient Alert Feature in Implantable Cardioverter Defibrillators:
  66. LETTERS TO THE EDITOR: 5
  67. Pulseless Atrial Fibrillation:
  68. Induction Ovens and Electromagnetic Interference:. What is the Risk for Patients with Implanted Pacemakers?
  69. Rate Responsive Pacing Using Transthoracic Impedance Minute Ventilation Sensors: A Multicenter Study on Calibration Stability
  70. Impact of Fusion Avoidance on Performance of the Automatic Threshold Tracking Feature in Dual Chamber Pacemakers: A Multicenter Prospective Randomized Study
  71. Pacemaker Reed Switch Behavior in 0.5, 1.5, and 3.0 Tesla Magnetic Resonance Imaging Units: Are Reed Switches Always Closed in Strong Magnetic Fields?
  72. Long-term follow-up and predictors of clinical outcome in patients with arrhythmogenic right ventricular cardiomyopathy
  73. Sudden cardiac death after coronary artery bypass grafting is not predicted by signal-averaged ECG
  74. MR Imaging in Patients with Cardiac Pacemakers
  75. Atypical Left Atrial Flutter after Intraoperative Radiofrequency Ablation of Chronic Atrial Fibrillation: Successful Ablation Using Three-Dimensional Electroanatomic Mapping
  76. Force and Torque Effects of a 1.5-Tesla MRI Scanner on Cardiac Pacemakers and ICDs
  77. The Impact of Automatic Threshold Tracking on Pulse Generator Longevity in Patients with Different Chronic Stimulation Thresholds
  78. Influence of Posture, Breathing Pattern, and Type of Exercise on Minute Ventilation Estimation by a Pacemaker Transthoracic Impedance Sensor
  79. Autonomic Nervous System-Controlled Cardiac Pacing: A Comparison Between Intracardiac Impedance Signal and Muscle Sympathetic Nerve Activity
  80. Clinical Evaluation of a Pacemaker Algorithm That Adjusts the Pacing Rate During Sleep Using Activity Variance
  81. Morphology Discriminator Feature for Enhanced Ventricular Tachycardia Discrimination in Implantable Cardioverter Defibrillators
  82. Effect of exercise training on heart rate variability in patients with new-onset left ventricular dysfunction after myocardial infarction
  83. Noncompaction of Ventricular Myocardium and Arrhythmias
  84. Influence of Acute Exposure to High Altitude and Hypoxemia on Ventricular Stimulation Thresholds in Pacemaker Patients
  85. Importance of AV Synchronous Pacing During Low Intensity Exercise Evaluated by Oxygen Kinetics
  86. Importance of Ventricular Rate After Mode Switching During Low Intensity Exercise as Assessed by Clinical Symptoms and Ventilatory Gas Exchange
  87. The Potential for Inappropriate Ventricular Tachycardia Confirmation Using the Intracardiac Electrogram (EGM) Width Criterion
  88. Acute Hemodynamic Effects of Alternate and Combined Site Pacing in Patients after Cardiac Surgery
  89. Potential proarrhythmic effects of implantable cardioverter-defibrillators
  90. Postmortem Analysis of Encapsulation Around Long-Term Ventricular Endocardial Pacing Leads
  91. Hospital Pager Systems May Cause Interference with Pacemaker Telemetry